## **Core Concept**
Disseminated intravascular coagulation (DIC) is a complex condition characterized by both widespread clotting and bleeding in the vascular system, resulting from an imbalance in the coagulation and anticoagulation mechanisms. Anti-thrombin III (AT III) is a critical anticoagulant protein that inhibits the coagulation cascade by inactivating thrombin and other clotting factors.

## **Why the Correct Answer is Right**
In DIC, there is consumption of coagulation factors and anticoagulant proteins, including anti-thrombin III, due to the widespread activation of the coagulation cascade. This consumption leads to decreased levels of AT III. The reduction in AT III levels contributes to the pro-coagulant state seen in DIC, as there is less inhibition of the coagulation cascade. Therefore, the correct answer reflects a decrease in anti-thrombin III levels.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Increased levels would not align with the consumption of AT III seen in DIC.
- **Option B:** No change would not accurately reflect the dynamic process of consumption and potential compensatory mechanisms in DIC.
- **Option D:** A variable decrease would not accurately describe the expected outcome; the condition leads to a discernible decrease in AT III levels.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in DIC, the levels of **anti-thrombin III are decreased** due to consumption. This decrease is significant because it can guide the management, including the potential use of AT III concentrates as part of the treatment strategy.

## **Correct Answer:** . Decreased.